Rafferty Asset Management, LLC Crispr Therapeutics Ag Transaction History

Rafferty Asset Management, LLC

$29.4 Billion
Q2 2025

A detailed history of Rafferty Asset Management, LLC transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Rafferty Asset Management, LLC holds 114,348 shares of CRSP stock, worth $7.51 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

114,348

Previous 146,032 21.7%

Holding current value

$7.51 Million

Previous $4.97 Million 11.91%

% of portfolio

0.02%

Previous 0.02%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$31.27 - $48.64 $990,758 - $1.54 Million	-31,684 Reduced 21.7%	114,348 $5.56 Million
Q1 2025 May 14, 2025	SELL	$34.03 - $53.02 $673,249 - $1.05 Million	-19,784 Reduced 11.93%	146,032 $4.97 Million
Q4 2024 Feb 14, 2025	SELL	$38.65 - $55.15 $1.87 Million - $2.66 Million	-48,278 Reduced 22.55%	165,816 $6.53 Million
Q3 2024 Nov 13, 2024	BUY	$44.62 - $62.75 $1.41 Million - $1.98 Million	31,533 Added 17.27%	214,094 $10.1 Million
Q2 2024 Aug 13, 2024	BUY	$51.17 - $68.18 $3.02 Million - $4.02 Million	58,987 Added 47.73%	182,561 $9.86 Million
Q1 2024 May 13, 2024	SELL	$60.67 - $89.12 $1.44 Million - $2.12 Million	-23,763 Reduced 16.13%	123,574 $8.42 Million
Q4 2023 Feb 13, 2024	SELL	$38.62 - $72.18 $1.62 Million - $3.04 Million	-42,050 Reduced 22.2%	147,337 $9.22 Million
Q3 2023 Nov 13, 2023	BUY	$45.39 - $59.0 $1.93 Million - $2.51 Million	42,478 Added 28.91%	189,387 $8.6 Million
Q2 2023 Aug 11, 2023	SELL	$43.47 - $67.77 $458,043 - $714,092	-10,537 Reduced 6.69%	146,909 $8.25 Million
Q1 2023 May 11, 2023	SELL	$41.0 - $56.12 $295,446 - $404,400	-7,206 Reduced 4.38%	157,446 $7.12 Million
Q4 2022 Feb 13, 2023	BUY	$39.19 - $65.67 $2.4 Million - $4.02 Million	61,206 Added 59.17%	164,652 $6.69 Million
Q3 2022 Nov 14, 2022	BUY	$61.1 - $83.78 $2.66 Million - $3.65 Million	43,569 Added 72.76%	103,446 $6.76 Million
Q2 2022 Aug 12, 2022	BUY	$43.23 - $73.83 $1.47 Million - $2.51 Million	34,015 Added 131.53%	59,877 $3.64 Million
Q1 2022 May 13, 2022	SELL	$53.19 - $79.24 $180,952 - $269,574	-3,402 Reduced 11.63%	25,862 $1.62 Million
Q4 2021 Feb 10, 2022	BUY	$70.09 - $111.29 $50,955 - $80,907	727 Added 2.55%	29,264 $2.22 Million
Q3 2021 Nov 10, 2021	SELL	$110.2 - $156.64 $330,710 - $470,076	-3,001 Reduced 9.52%	28,537 $3.19 Million
Q2 2021 Aug 10, 2021	BUY	$100.84 - $161.89 $3.18 Million - $5.11 Million	31,538 New	31,538 $5.11 Million

Others Institutions Holding CRSP

# of Institutions

544

Shares Held

68.5M

Call Options Held

3.67M

Put Options Held

2.25M

View Full List

About CRISPR Therapeutics AG

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $5.13B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

More about CRSP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rafferty Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rafferty Asset Management, LLC with notifications on news.

Account

Rafferty Asset Management, LLC Crispr Therapeutics Ag Transaction History